Annual Clinical Contract Evaluations: Are You Ready?

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $99.00

CEC Hours: 1

Order Webinar

 

Description:

The process of annual clinical contract evaluations can be time consuming and overwhelming, and supply chain has a unique opportunity to support the continuum of care as we expand our CQO efforts and strive to meet requirements. In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract performance with the use of key performance indicators.

Attendees will hear firsthand what the Dana-Farber Cancer Institute (DFCI) learned during their last Joint Commission inspection regarding the evaluation process and the effectiveness of their contracts. In addition, DFCI will share how their annual clinical contract evaluation process has matured through the improvement of existing contract management technology and the automation of the evaluation process.

 

Learning Objectives:
  • Characterize a clinical contract.
  • Explain the annual clinical contract evaluation requirements.
  • Define key performance indicators.

 

Presenters:
  • Sarah Buck — Supply Chain Business Analyst, Dana-Farber Cancer Institute
  • Susan Wills — Director Strategic Sourcing and Contracts, Dana-Farber Cancer Institute

 

Related Resources

Advisory
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Educ
Advisory
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Magazine & Journal Articles
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…